NPCENeuroPace, Inc.
What is the market doing?
No clear lean: nothing decisive, though in a downtrend (−14% vs 200-day).
In a downtrend, below its 50- and 200-day averages. Price is −14% vs its 200-day average.
Lightly shorted, settled Sep 30, 2026, about a week of normal trading to cover.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How NPCE is trading
NeuroPace, Inc. is +19% over the past year while the S&P 500 is +16%: 3.1 points ahead of the market.
1-year return · S&P 500 +16%
- vs 200-day average
- −14%
vs 200-day average · a clear downtrend
- RSI (14)
- 47
RSI (14) · neutral
- Below its 52-week high
- 33%
Below its 52-week high
Details›
- Last close2026-10-23
- $12.91
- 1 monthS&P 500 −0.94%
- −7.6%
- 1 yearS&P 500 +16%
- +19%
- 5 yearsS&P 500 +86%
- −18%
- vs 50-day average$13.83
- −6.7%
- 52-week high
- $19.29
- 52-week low
- $9.40
- Annualised volatility
- 68%
| Year | Return |
|---|---|
| 2026 (year to date) | −16% |
| 2025 | +38% |
| 2024 | +8.5% |
| 2023 | +592% |
| 2022 | −85% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 5 | 3 of 5 | +51% |
| Feb | 5 | 2 of 5 | +1.5% |
| Mar | 5 | 1 of 5 | −7.5% |
| Apr | 5 | 2 of 5 | +5.5% |
| May | 6 | 1 of 6 | −12% |
| Jun | 6 | 3 of 6 | −4.3% |
| Jul | 6 | 2 of 6 | −6.7% |
| Aug | 6 | 4 of 6 | +20% |
| Sep | 6 | 2 of 6 | −6.5% |
| Oct | 6 | 0 of 6 | −12% |
| Nov | 5 | 3 of 5 | +16% |
| Dec | 5 | 3 of 5 | +1.6% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.